{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:00:11Z","timestamp":1770487211132,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1992,6,1]],"date-time":"1992-06-01T00:00:00Z","timestamp":707356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":10118,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1992,6]]},"DOI":"10.1093\/oxfordjournals.annonc.a058232","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T17:14:33Z","timestamp":1486142073000},"page":"445-449","source":"Crossref","is-referenced-by-count":21,"title":["Phase I\/II study of liposome-complexed mitoxantrone in patients with advanced breast cancer"],"prefix":"10.1016","volume":"3","author":[{"given":"B.","family":"Pestalozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Schwendener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chr.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0005","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/jnci\/81.19.1436","article-title":"Liposomal encapsulation: making old and new drugs do new tricks","volume":"81","author":"Brenner","year":"1989","journal-title":"J Nail Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0010","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/archinte.1989.00390110097022","article-title":"Treatment of systemic fungal infections with liposomal amphotericin B","volume":"149","author":"Lopez-Berestein","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0015","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/82.21.1706","article-title":"Antitumor activity of lipo-some-encapsulated doxorubicin in advanced breast cancer phase II study","volume":"82","author":"Treat","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0002-9378(89)90296-2","article-title":"A phase I\/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer","volume":"160","author":"Delgado","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0025","first-page":"789","article-title":"Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent","volume":"4","author":"Sculier","year":"1986","journal-title":"A pilot study with pharmacokinetic data. J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0030","series-title":"Liposomes in the therapy of infectious diseases and cancer","first-page":"95","article-title":"Treatment of acute myelogenous leukaemia with liposomes containing N4-oleyl-cytosine arabinoside","author":"Schwendener","year":"1989"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0035","first-page":"6462","article-title":"Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles","volume":"47","author":"Perez-Soler","year":"1987","journal-title":"Cancer Res"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0040","first-page":"4254","article-title":"Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane Platinum (II)","volume":"50","author":"Perez-Soler","year":"1990","journal-title":"Cancer Res"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0045","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1200\/JCO.1989.7.12.1915","article-title":"Phase I trial of liposomal muramylpeptide phosphatidylethanolamine (MTD-PE(CGP 19835A)) in cancer patients","volume":"7","author":"Murray","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/1097-0142(19880901)62:5<905::AID-CNCR2820620509>3.0.CO;2-3","article-title":"Successful imaging of human cancer with Indium-111-labeled phospholipid vesicles","volume":"62","author":"Presant","year":"1988","journal-title":"Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00685156","article-title":"Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy","volume":"27","author":"Schwendener","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0060","first-page":"707","article-title":"Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinoma 26 and 38","volume":"78","author":"Mayhew","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0065","first-page":"26","article-title":"Liposomal Mitoxantrone (L-Mto) is effective in metastatic breast cancer","volume":"9","author":"Pestalozzi","year":"1990","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0140-6736(90)90277-C","article-title":"Comparison of short-term and continuous chemotherapy (mitoxantrone) for advanced breast cancer","volume":"335","author":"Harris","year":"1990","journal-title":"The Lancet"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/cdd.1986.3.123","article-title":"The preparation of large volumes of homogeneous, sterile liposomes containing various lipophilic cytostatic drugs by the use of a capillary dialyzer","volume":"3","author":"Schwendener","year":"1986","journal-title":"Cancer Drug Deliv"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"10","key":"10.1093\/oxfordjournals.annonc.a058232_bb0085","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.annonc.a057845","article-title":"Multicenter v. single center phase II evaluation of 4\u2032-iodo-4\u2032-deoxydoxorubicin in advanced breast cancer","volume":"2","author":"Schwartsmann","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-105-5-805_3","article-title":"Mitoxantrone and hepatic toxicity","volume":"105","author":"Paciucci","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00292881","article-title":"Pharmacology of mitoxantrone in cancer patients","volume":"8","author":"Savaray","year":"1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF00258459","article-title":"Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection","volume":"23","author":"Lai","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/oxfordjournals.annonc.a058232_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.1990.8.1.146","article-title":"Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer","volume":"8","author":"Markman","year":"1990","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419652622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419652622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/3\/6\/445\/630163\/3-6-445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T02:41:41Z","timestamp":1582252901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419652622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["S0923753419652622"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a058232","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}